1. Introduction
Tuberculosis (TB), caused by the opportunistic pathogen Mycobacterium tuberculosis (M.tb), is a deadly disease and a major cause of death globally, [1] The prognosis of TB is further worsened due to co-morbid conditions, such as infections of HIV, and now the ongoing COVID-19 pandemic is posing additional challenges [2]. The emergence of drug resistant forms (MDR and XDR) of M.tb is a cause of concern as it has slowed our efforts to eradicate TB worldwide [3]. Macrophages are primarily efficient in clearing pathogens; however, M.tb can survive intracellularly within the niche of macrophage itself. M.tb has evolved various mechanisms that allow it to hijack the process of phagosome-lysosome fusion, inhibit acidification of phagosome, suppress autophagy and apoptosis pathways used by macrophage for the clearance of pathogens [4,5,6,7]. M.tb overpowers the extremely microbicidal nature presented within the macrophages through a multifaceted and complex interplay between its proteins and host immune responses [8,9]. Several M.tb proteins have been reported to evoke innate and adaptive immune responses, though many of these act as decoy antigens to subvert the immune system. Decoy antigens mimic host-pathogen effector components and can misdirect the immune response pathways that favor the survival of the pathogen. Pathogenic bacteria such as M.tb also use decoy proteins as a generic mechanism to mask themselves from immune surveillance, thereby evading and subverting host immune responses [10,11]. The decoy antigens can be classified into three broad categories, namely, receptor, bodyguard and sensing decoys. As the name suggests, receptor decoys are employed by the pathogens to modulate host immune signaling pathways. In contrast, bodyguard decoys act as inactive mimics to safeguard the virulence factors of pathogens from the host response. Sensing decoys mimic the effector functions of the target proteins of both the host and the pathogens [12].
The mycobacterial PE/PPE/PE_PGRS protein family, present only in the genus mycobacterium and nowhere else in the living kingdom, occupies approximately 10% of the coding capacity of the M.tb genome. Despite the reductive genomic evolution of M.tb [13], the PE/PPE/PE_PGRS family of genes has been expanding during mycobacterial evolution. The presence of this family only in pathogenic strains of the genus mycobacterium, such as M.tb, M.marinum and M.bovis, points to its likely importance in disease pathogenesis [14]. The evolution of PE/PPE gene families was found to be associated with the ESX secretion system [15], and proteins were majorly reported to be either surface exposed or secreted [16,17,18]. Cell-surface localization of PE/PPE/PE_PGRS proteins may serve an important function in host-pathogen interactions and in the virulence and pathogenesis of M.tb [19]. PE_PGRS (polymorphic GC-rich sequences) proteins are a subclass of the PE protein family and consists of a highly conserved N-terminal (approx. 110 amino acid long) the PE domain followed by the C-terminal domain harboring multiple repeats of Gly-Gly-Ala or Gly-Gly-Asn. Deciphering the role of proteins belonging to the PE_PGRS family may reveal new aspects of the biology of M.tb. The presence of multiple tandem repeats of GGA or GGN has been attributed to cause antigenic variations and aid in immune evasion mechanisms, thereby facilitating pathogen survival. The repetitive nature of PE_PGRS proteins and their surface localization both lead to the generation of immune responses by macrophages and may aid in immune subversion [17].
In this review, we highlight the various hypothesis and published data to showcase the role of antigenic M.tb PE/PPE/PE_PGRS proteins in evading and subverting host immune responses, which in turn favor M.tb survival and dissemination. It is envisaged that a better understanding of PE_PGRS proteins shall provide crucial insights about M.tb virulence and immune evasion and may aid in designing alternative approaches to design better vaccines and therapeutics.
2. Modulators of the Host-Immune Response: PE/PPE Proteins
PE_PGRS and PPE-MPTR (major polymorphic tandem repeat) make up the majority of the PE/PPE proteins, which are associated with cell wall and are secretory in nature [20,21]. These proteins play an important role in the development of mycobacterial pathogenicity by modulating the host immune system. PE and PPE protein are implicated in the manipulation and evasion of the host immune system. M.tb primarily infects the macrophages, which act as a reservoir for the pathogen. The expression pattern of these proteins is significantly altered in M.tb when it infects the macrophage, pointing to their role in virulence [22]. M.tb uses a variety of ways to counteract macrophage-mediated protective mechanisms [23]. M.tb exploits an extra lipoidal cell wall with the presence of PDIM (phthiocerol dimycocerosates) to protect the pathogen from the host’s innate immune surveillance. Before the adaptive immune response kicks in, M.tb establishes itself in the host macrophages [24,25]. A number of PE/PPE proteins influence macrophage activity by modulating or changing the cellular dynamics. M.tb pathogenicity is influenced by the Esx5 secretion system and its substrates, which include associated and non-associated PE/PPE proteins.
Although there is evidence that PE/PPE proteins have a variety of roles in modifying the host intracellular milieu during infection, more research is necessary to understand this. Many PE/PPE proteins control the host immune response by upregulating the production of cytokines that trigger pro-inflammation or anti-inflammation [23,26,27,28]. PPE37, for example, modulates the pro-inflammatory response in the host by lowering the production of IL-1β, IL-6, and TNF-α [29]. PE5- and PE15-expressing M. smegmatis recombinants increased the intracellular bacterial survival in the host, suggesting that they may play a role in the host-pathogen interaction. Infected macrophages showed up- and down-regulation of IL-4, IL-5, IL-10, and TGF-β (anti-inflammatory cytokines), and IL-12 (pro-inflammatory cytokine). PE5, PPE15 and PPE2 inhibit reactive nitrogen species’ production and are predicted to be an anti-mycobacterial strategy of the host [30,31].
T-lymphocytes are important contributors in the secretion of the cytokines. A critical balance between the Th-1 and Th-2 subsets of the T-lymphocytes drives the response against varied infections. Th1 response is critical in wiping out the intracellular pathogens whereas Th-2 is essential in clearing the extracellular infections. Th1 polarization is inclined towards the secretion of the pro-inflammatory cytokines and thus attracts the cytotoxic cell population towards the infected cells to handle the intracellular pathogens. On the contrary, Th-2 polarization is involved in the clonal expansion of the B-cells which leads to an increase in the antibody titres in the system that act on the extracellular pathogens. Th2 cells also secrete anti-inflammatory cytokines such as IL-1, IL-4 and IL-10, etc. During inflammation, due to mycobacterial infection, Th-1 polarization is important to clear the infection from the infected tissues. However, it should be balanced by the Th-2 response to control the Th-1 mediated excessive tissue damage. Consequently, to counter host defense, several PE/PPE proteins, such as PE4, PE5, and PE15, disrupt Th-1 and Th-2 equilibrium, bypassing the host immune response and allowing bacteria to survive longer inside macrophages [30,32]. The sera of the TB patients generated a substantial antibody response when probed against the antigen PPE41 [33,34]. The co-translated PE32/PPE65 heterodimer has recently been shown to influence host immune response in favor of the pathogen by dampening the Th-1 response [35]. The Esx5 associated PE paralogs PE18 and PE19 twisted the equilibrium towards Th1 bias [36]. PE/PPE proteins that drive the Th-1 response might play a role in diverting the immune attention away from the major virulent effectors of M.tb.
PE13, which establishes cell wall function, was also discovered to be implicated in the interplay between pathogen and host signaling, via the p38-ERK-NF-κB axis. It induces macrophage apoptosis and subsequent cell-to-cell dispersion, resulting in increased mycobacterial survival in macrophages over time. PE13 boosted macrophage secretion of IL-1 and IL-6 and decreased the suppressor of cytokine signaling 3 (SOCS3) synthesis [37]. PPE32, such as PE13, promotes mycobacterial intraphagocyte survival through an aberrant increase in cytokine production, particularly IL-12 and IL-32 [38]. ESAT-6 and PPE25, proteins implicated in both bacterial pathogenicity and host immune recognition, were found to interact in M. avium. PPE25 was shown to be localized to the bacterial cell membrane after being expressed in M. smegmatis [39]. The localization of PPE25 in the cell membrane suggests that it would install a direct contact with the host’s immune system during infection.
PE11, also known as LipX, is shown to be elevated in active tuberculosis patients and is restricted to the pathogenic mycobacterial species. It promotes virulence by changing the structure, composition, or alignment of the outer cell wall [40]. PE_PGRS62, PE_PGRS30, and PPE25 (homolog from a subspecies of M. avium) have also been linked to mycobacterial virulence and have been shown to hinder phagosome maturation [41]. The ppe38 deletion mutant of M. marinum modified the bacterial cell surface properties, lowering pathogenicity via reducing macrophage phagocytic functions [42]. When the complete pe/ppe genetic stretch was removed from the esx-5 gene locus, the deleted M.tb mutant (Δppe25–pe19) showed attenuation in host macrophages as well as in the severe combined immunodeficient mice infection paradigm [20].
Only pathogenic mycobacteria have the ability to infect new uninfected cells, implying that M.tb colonizes and multiplies by modulating programmed cell death [43]. We earlier reported that PGRS domain of PE_PGRS5 protein is implicated in TLR4-dependent endoplasmic reticulum (ER) stress-mediated cell death, which may aid pathogen dispersion later in infection [44]. Furthermore, we demonstrated that low cellular iron content causes PPE37 to be proteolytically cleaved, resulting in two segments at the N and C termini, respectively. These segments are responsible for their extracellular and nuclear localization, with the C-terminus inducing apoptosis and the N-terminus modulating the host immune response to favor the pathogen [45]. Furthermore, it was postulated that the PE25/PPE41 heterodimer promotes necrosis in macrophages, rather than apoptosis, to aid in bacterial multiplication and spread, perhaps leading to disease reactivation [46]. However, the significance of apoptosis in M.tb infection, disease establishment, and proliferation is yet unknown and hotly debated. Necrotic cell death, on the other hand, is a similar mechanism that facilitates in the spread of bacterial cells from pre-infected macrophages to infect new cells [46]. It is unclear how M.tb causes host cell necrosis while also managing its proliferation, especially during the latency phase. To successfully resist the humoral and cell-mediated adaptive immune responses of the host against the established infection, mycobacteria employ necrosis as a cell death mechanism. Dheenadhayalan et al. showed that recombinant M smegmatis expressing M.tb PE_PGRS33 exhibited increased persistence within the macrophages as compared to the parental strain of M smegmatis. A significantly higher number of nucleosomes in the culture supernatant of the macrophages infected with M smegmatis expressing PE_PGRS33 pointed to greater cellular destruction. It was found that PE_PGRS 33 altered the levels of TNF secretion in the macrophage, which not only induced necrosis of the cell but also enhanced the survival of the recombinant M smegmatis expressing PE_PGRS within the infected macrophages [47]. M smegmatis expressing PE_PGRS33 induced necrosis in macrophages similar to that caused by infection with virulent M tuberculosis, while M smegmatis expressed only that the PE domain failed to induce cell death. This study pointed that the PGRS domain of the PE_PGRS protein can have a specific role in part in inducing necrosis in macrophages.
3. Ambiguous Immune Responses of PE/PPE/PE_PGRS Proteins of M.tb
Numerous studies focusing on the moonlighting functions of the PE/PPE/PE_PGRS family of proteins revealed their diverse functional implications in M.tb pathogenesis during the course of infection. It is of prime importance to note that, while a dozen of these proteins induce pro-inflammatory immune responses, others mount anti-inflammatory responses via separate signaling cascades. The fine-tuning between the two eventually decides the outcome of the disease progression and pathogen survival.
PE/PPE/PE_PGRS proteins serve as possible virulence factors and act as a source of antigenic variation in different M.tb clinical strains [17,22]. In silico comparative genomic and proteomic analysis of PE/PPE/PE_PGRS proteins revealed significant differences between their sequences in M.tb H37Ra and H37Rv; that have been translated in terms of specific globularity and antigenicity indexes of these proteins; it is thereby hypothesized to serve as a potential basis for the differences in their immunogenic profiles [48]. PE-PGRS11 and PE_PGRS17, both cell wall associated proteins, have been shown to evoke activation and maturation of human dendritic cells along with DC-induced stimulation of CD4+ T-cells and enhanced pro-inflammatory cytokine responses [49]. The PGRS domain of Rv0297 encoded PE_PGRS5 leads to the production of TNF-α and IL-12 in infected macrophages [50] along with apoptosis induction [44]; the response generated was shown to be dependent on calcium ions [51]. PE_PGRS33, coded by Rv1818c, was observed to induce TNF-α; an important anti-mycobacterial cytokine, in a TLR-2 dependent manner [26]. The highly disordered nature of the PGRS domain of PE_PGRS33 enables it to aid the bacterium to enter the macrophages efficiently [52]. The PE and PGRS domains of PE_PGRS33 evoke an unusual immune response against M.tb; PE domain vaccinated mice splenocytes elicited cellular responses and IFN-γ production, while humoral response was induced by immunization with the PGRS domain and not by the PE domain alone of PE_PGRS33 [53]. Antibody responses against the PGRS domain of PE-PGRS33 had also been evident [54]. Higher B cell responses against PPE41, an immunologically important protein coded by Rv2430c, in comparison to PPD and Hsp10 has also been reported in TB patients [33]. Mycobacterium smegmatis over-expressing PE_PGRS33 and PE_PGRS26 promoted IL-10 cytokines in infected macrophages [55]. Up-regulation of pro-inflammatory cytokines, such as IL-6, IL-12p40, IL-1β and TNF-α, accompanied by pathogen survival was detected in response to PPE32 and PPE60 [38,56]. M. smegmatis expressing Rv1195 encoded PE13 was shown to increase IL-6 and IL-1β from infected macrophages through the p38-ERK-NF-κB host-signaling pathway [57]. Rv0335c encoded PE6, a secretory protein of M.tb, subdues immune responses by promoting the secretion of IL-12, IL-6 and TNF-α, most important pro-inflammatory cytokines from host macrophages in TLR4 and Myd88 dependent manner [58]. IFN-γ and IL-2 have been shown to be upregulated from polarized Th-2 cells and pro-inflammatory cytokines (TNF-α, IL-6 and IL-12p40) in response to PPE57 of M.tb [57,59]. PE3 was overexpressed during the chronic infection of M.tb and immunization with PE3 results in elevated protective immune response. [60] Bottai et al. have shown that Δppe25–pe19 mutant of M.tb provided a strong attenuation and protection due to cross reactivity of the PE/PPE family of protein [20].
An anti-inflammatory response in macrophages due to the PE_PGRS30 protein in terms of the reduced production of IL-12, TNF-α and IL-6 has also been discovered [61,62]. PPE38 has been known to modulate the secretion of several other mycobacterial PE/PPE proteins and dampens host pro-inflammatory immune responses [63]. PPE18 triggers anti-inflammatory Th2 responses from macrophages by promoting IL-10 cytokines in TLR-2/MAP kinase supported pathway [64]. M.tb is exemplified by the suppression of pro-inflammatory cytokines (TNF-α and IL-12) for maintaining a Th-2 response to favor infection progression and eventual bacterial survival. Nair et al. demonstrated the anti-inflammatory roles of PPE18 in terms of suppressing TNF-α and IL-12p40 pro-inflammatory cytokine production by obstructing the nuclear translocation of transcription factors, such as NF-κB, c-rel, p50, and p65 [65]. PPE41, a highly polymorphic protein coded by Rv2608, has been reported with respect to its ability to induce significantly higher B-cell responses and decreased T-cellular responses [66]. PPE34 coded by Rv1917c has been shown to involve in TLR-2 dependent maturation of DCs and the subsequent secretion of very high amounts of IL-10, IL-4 and IL-5 anti-inflammatory cytokines; the production of Th-1 skewed IL-12 was not observed in response to PPE34 thereby supporting its immune evasion properties during the course of mycobacterial infection [28]. PE5 (Rv0285) and PE15 (Rv1386) modify host immune response by enhancing IL-10 and diminishing IL-12p40 cytokine levels [30]. PPE37, consisting of disordered stretches, involved in iron sequestration also leads to the secretion of high levels of IL-10 but IL-12 and TNF-α are barely detectable; thus, serving as a suitable environment for sustaining tolerant immune cells. Significant immune sero-reactivity was also observed in response to full length PPE37 protein in TB patients [45]. Another protein PE_PGRS62 was reported to exhibit induction of IL-1β and IL-6 from macrophages [67,68]. A domain-specific study exposed the preferential recognition of full-length PE_PGRS17 and PE_PGRS62 over PE domains alone [69]. Two other members of this family, PPE18 and PPE_MPTR34, were also known to modulate host responses in a TLR2-dependent manner [28,64].
M.tb further exploits the additional complexity of the co-operonic nature of PE/PPE protein pairs to evade the associated immune machinery by modifying Th-1 and Th-2 dependent immune balance to favor bacillary survival and the progression of disease outcomes [35,46,70,71,72]. M.tb PE9–PE10 heterodimers and co-operonic PE35-PPE68 interact with TLR-4 of macrophages to suppress levels of pro-inflammatory molecules IL-12 and IL-1β; upsurges that of IL-10 and monocyte chemo attractant protein-1 (MCP-1) [73]. Higher humoral response along with significant IFN-γ and TNF-α cytokine production against PPE41 and PE25/PPE41 co-operonic complex in comparison to PE25 alone has been depicted in TB patients’ sera [34]. Substantially higher levels of TNF-α production have been shown in macrophages stimulated with PE25/PPE41 complex protein; however, interestingly it did not mount IL-10 cytokine levels [34]. Mice immunized with co-operonic a PE32/PPE65 protein pair showed inhibition of Th-1 immune cytokines such as IFN-γ and IL-2 with high levels of IgG1 in serum depicting the modulation of immune responses [35]. PE/PPE proteins have also been hypothesized to act as possible exporters to augment mycobacterial virulence and pathogenesis [74].
The diverse functions of PE/PPE/PE_PGRS proteins in both subverting and stimulating immune responses are thus evident thereby hindering an appropriate cellular response required for the containment of disease [75]. Thus, further explanation of the molecular or cellular basis of such contradictory responses of these proteins belonging to same family and of almost similar structure is of utmost importance. It can be noted that the highly disordered nature of multiple stretches in these proteins (discussed below) might play an eminent role in either evoking or diminishing immune responses that augment the pathogenesis of TB.
4. Immune Evasion and Subversion Properties of PE_PGRS Proteins: A Possible Reflection of Antigenic Variation, Disordered Nature and Glycine Content
During the course of evolution, pathogenic bacteria developed multiple strategies to avoid or subvert host machinery, especially the mechanisms that drive protective outcomes of host immune response [76,77]. Pathogens also manipulate the outcome of the host’s immune response by altering antigen presentation pathways and engaging host immune machinery with multiple antigens [78,79]. M.tb utilize extremely progressive and harmonized mechanisms of immune evasion that divert or subvert the host proteins involved in neutralizing the virulence of the pathogen. In doing so, the host machinery gets engaged in evoking immune responses against the decoy antigens, thereby neutralizing the efficacy of host immune response in bacterial clearance [10,11]. Multiple PE_PGRS proteins evoke different signals that allow the pathogen to evade the host immune response [80]. PGRS domain of PE_PGRS62 protects the PE protein from ubiquitin-proteasome mediated degradation and also affects the ability of the CD8+ T-cells to recognize the protein, thereby conferring protection to the pathogen present within the macrophages [81].
Several pathogens employ intrinsically disordered proteins (IDPs) or disordered short stretches for a variety of moonlighting functions [82,83,84]. IDPs, by virtue of their conformational plasticity and short interaction motifs, can interact with different protein partners [85]. Such disordered effector proteins perturb host cellular cascades via favorable interactions through molecular mimicry in both viruses and bacteria [83,84,86]. The PGRS domain of PE_PGRS proteins lacks a definite three-dimensional (3D) structure and is intrinsically disordered in nature [16,44,45,87]. The transition from an ordered to a disordered state or vice versa will serve to hijack host immune machinery for subsequent survival of the pathogen [13,16,88].
The generation of antigenic variation is one of the passive mechanisms of immune evasion and subversion [89,90]. PE/PPE/PE_PGRS proteins are known to provide a major source of antigenic variations in M.tb and its clinical isolates [17,59]. Thus, their prospective importance in acting as a decoy antigen to the host is emphasized. The interaction of M.tb with macrophage offsets the Ca2+ signaling that causes abnormality in phagosome maturation. Ca2+ binds with the PE_PGRS33 and PE_PGRS61 proteins [80,91]. These calcium dependent PE_PGRS proteins decrease the Ca2+ concentration during the initial phase of non-specific attachment of M.tb with the alveolar macrophages. The decrease in the Ca2+ in the macrophage suppresses the phagolysosomal fusion of the M.tb with the acidic lysosome; thereby contributing to the survival of the M.tb. PE_PGRS 33 and PE_PGRS41 are cell wall associated proteins. While the PE domain of the PE_PGRS 33 is important for cellular localization, the PGRS domain of this protein is important for cellular morphology of the bacterium and its entry within the host cells. Knock-in of the PE_PGRS33 gene in M smegmatis imparts endurance to the bacterium to overcome the cytotoxic effect of the macrophage and enhances the level of TNF. Although M smegmatis does not effectively infect host cells, recombinant strains of M smegmatis expressing PE_PGRS33 can colonize the lungs, spleen and liver, which is a typical feature for virulent M tuberculosis [88]. Ramakrishnan et al. showed that pathogenic M.marinum expresses two proteins (mag 24 and mag 85) that are homologous with M.tb PE_PGRS protein family, and are involved in granuloma formation and the replication of the pathogen within the macrophage [92]. Mice immunized with the PE domain of the PE_PGRS 33 exhibit a higher cell-mediated response while immunization with the complete PE_PGRS 33 leads to increased humoral response [53]. These studies also suggest that differential expression and the regulation of PE/PE_PGRS protein family during M.tb infection play a key role in enhancing the virulence features of the pathogen.
The VaxiJen antigenicity prediction tool shows a high antigenicity index for PE_PGRS proteins (Figure 1). The antigenicity index of PE_PGRS proteins increases as a direct function of the glycine content of these proteins (Figure 2). PGRS domain of PE_PGRS proteins was observed to be highly rich in glycine, with major chunks of Gly-Gly-Ala stretches similar to EBNA-1 antigen [81]. Glycine, a highly conserved amino acid, is known to initiate several protective and immunomodulatory responses in the host cells. Glycine modulates the function of the macrophage and evokes inflammatory cytokines, as compared to other amino acids [93]. Cell wall proteins that are rich in glycine exhibit greater antigenicity and are notable targets in several autoimmune and food borne allergies. It is important to note that the presence of high glycine content in proteins with high antigenicity indices is not just a matter of chance but points to the role of glycine-rich proteins in non-specific but targeted protective immune responses from host macrophages.
The role of PE_PGRS proteins in the immune evasion mechanism is attributed to varied and diverse patterns of the cytokine profile during M.tb infections [57]. While some of the PE_PGRS family of proteins, such as PE_PGRS5, PE_PGRS11, PE_PGRS17 and PE_PGRS30, evoke pro-inflammatory responses; others such as PE_PGRS26 are known to induce anti-inflammatory responses. This shows that PE_PGRS have contrasting roles in immune response and can act as a molecular switch for skewing the response as pro-host or pro-pathogen during tuberculosis [14,59]. The partial homology of PE-PGRS with EBNA domain of the Epstein–Barr virus speculates that it may play a role in the evasion of cytotoxic T-cell response to inhibit antigen processing [53,94].
Protein antigens are processed through the MHC (major histocompatibility complex) class I and MHC class II. MHC I is ubiquitously expressed on nucleated cells whereas MHC II is expressed on antigen presenting cells (APCs) including macrophages, dendritic cells, etc. Within the macrophage, M.tb secreted proteins are processed into smaller peptides and presented through the MHC II to the T-cells [95]. The proteins are processed through the proteasomal degradation machinery of the cell, which are translocated to the endoplasmic reticulum through the transporters associated with antigen processing (TAP) proteins [96]. CD4+ T cells recognize these processed antigens primed on the MHC II leading to the generation of effector and memory T-cell response against the antigenic peptides. M.tb involves multiple mechanisms to prevent or bypass antigen presentation processes (pathways) by inhibiting the truncation of secreted proteins into 8–25 amino acid long short peptides, required for the MHC II pathway [10,95,97]. Phagosomes, the main component of the MHC class II mediated classical antigen presentation pathway is a critical spot within the macrophages that is hijacked by the M.tb, resulting in inhibition of the proteasomal processing of secreted antigens. Thus, M.tb antigens within the macrophage are masked from being recognized by the T-cells, thereby protecting M.tb from cellular immune response [98]. PE/PPE/PE_PGRS proteins could be expressed as the early immunodominant antigens followed by the other functionally dominant but immuno-subdominant virulence factors. PE_PGRS proteins neutralize the effector functions of the host immune system, thereby acting as “decoy” for allowing the safe passage of other important effector molecules of the pathogen within the internal proximity of the host. Effector T cells primed against the decoy immunogen search for similar antigens throughout the cells of the host, which are discontinued by the pathogen during a subsequent phase of infection. In this way, the dominant virulent factors of M.tb remain unaffected by the cell-mediated immune response. The consequent subversion of T-cell response allows the bacteria to successfully establish its pathogenicity and disease progression within the host [99].
Several members of the PE_PGRS protein family were shown to induce a wide range of contradictory T-cell and B-cell responses as described in earlier sections [100]. Such responses are not specific to this protein family, rather a generalized and diverse immune profile have been observed [57]. PE_PGRS11 and PE_PGRS17 proteins are involved in the activation and maturation of human dendritic cells and boost pro-inflammatory responses [49]. The PE and PGRS domain of PE_PGRS33 evoke different immune response against M.tb. Mice immunized with PE domain of Rv1818c elicited cellular responses and IFN-γ production, while the humoral response was induced upon immunization with the PGRS domain and not by the PE domain alone [53]. Another study showed the generation of B-cell responses against the PGRS domain of PE_PGRS33 [54]. M.smegmatis over-expressing PE_PGRS33 and PE_PGRS26 show enhanced production of IL-10 cytokine levels in macrophage cell lines [55]. An anti-inflammatory response of macrophages due to the PE_PGRS30 protein in terms of the reduced production of IL-12, TNF-α and IL-6 was reported [61]. PE_PGRS33 is linked with the increased production of TNF-α and IL-10, and reduced levels of IL-12p40 [47]. In contrast, the expression of PE_PGRS16 enhances IL-12p40 levels but reduces IL-10 cytokine production [55]. The immune response generated by PE_PGRS16 was antagonistic to that of PE_PGRS26 [55,101]. These studies show that the PGRS domain plays a key role in PE_PGRS proteins and is an important target for manipulating immune response.
The elicitation of antibody responses specifically directed against the glycine and asparagine repeats has been reported [66]. PPE18 and some other 20 PE proteins have been shown to generate CD4 or CD8 mediated T-cell responses [102]. Th-2 responses and reduced IFN-Υ levels have been detected against PPE44 protein of M.tb [103]. PGRS domain of PE_PGRS5 protein induce TNF-α and IL-12 cytokines in macrophages [50] in a calcium dependent manner [51].
One of the most widely used anti-TB vaccine strains, BCG, is not fully capable of secreting a class of PE/PPE family proteins (specifically PE_PGRS and PPE-MPTR) due to the absence of the RD5-genetic region (containing functional Esx-5 and PPE38/71 involved in secretion) [104]. The BCG vaccine elicits a reduced repertoire of antigens during infection. In order to assess the immunogenic potential of PE/PPE/PE_PGRS proteins, Ates et al. restored the BCG strain with PPE38 locus, which improved the PE_PGRS and PPE_MPTR secretion in infected mice. Restoration of PE_PGRS and PPE_MPTR secretion neither enhanced the activation of immune cells nor boosted the protective efficacy of the restored BCG mutant strain [104]. Further studies are warranted to reveal the role of PGRS domain in improving the efficacy of recombinant BCG.
To summarize, these observations show that PE PGRS proteins have a variety of contrasting implications, not simply the PGRS domain, which may aid in evasion and modification of immune effector activities, and hence undermine the targeting of other critical mycobacterial pathogenic proteins (Figure 3 and Figure 4). This subversion may influence the course of disease pathogenesis and lead to higher survival rates of M.tb within alveolar macrophages. These observations are a pointer to reconsider the immunomodulatory effects of PE/PPE/PE_PGRS proteins (Table 1, Table 2, Table 3 and Table 4), few of which are considered in vaccine formulations. Understanding the mechanisms of the PE/PE_PGRS family of proteins in evading and subverting immune responses may aid in targeting these proteins for future therapeutic interventions.
T.S., S.E.H. and N.Z.E. conceptualized the manuscript; T.S. and A.E. performed the experiments and analysis; T.S., A.A., A.E., S.E.H. and N.Z.E. wrote the manuscript; T.S., A.A., A.R., A.E. and S.G. provided critical inputs and edited the manuscript. All authors have read and agreed to the published version of the manuscript.
S.E.H. and N.Z.E. are supported by the North-East Grants BT/PR23099/NER/95/632/2017 and BT/PR23155/NER/95/634/2017 of Department of Biotechnology, Ministry of Science and Technology, Government of India (GOI).
Intramural funds of the Indian Council of Medical Research (ICMR)—National Institute of Pathology are gratefully acknowledged. S.E.H. is a National Science Chair, Department of Science and Technology, Government of India and Robert Koch Fellow, Robert Koch Institute, Berlin, Germany.
All authors disclose that there is no conflict of interests.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figure 1. (A) Antigenicity index of PE_PGRS proteins of M.tb, as predicted by antigenicity prediction tool VaxiJen. (B) Glycine content of PE_PGRS proteins of M.tb calculated by ExpasyProtParam tool. All values were plotted in increasing order of their magnitude.
Figure 2. Antigenicity index of PE_PGRS proteins increases with increase in glycine content of PE_PGRS proteins. Antigenicity index was plotted against glycine percentage in linear ratio.
Figure 3. M.tb PPE_PGRS antigens play a role of virulent determinants by acting as an immunological decoy to capture the host immune machinery and evoke varied immune responses. This aids in evasion and subversion of host immune cellular functions during M.tb infection.
Figure 4. PE/PPE proteins augment the immune system of the host using decoy strategies. M.tb infection is most commonly found in macrophages, where the pathogen is endocytosed and transported to the endosome compartment. M.tb secretes non-PE/PPE and PE/PPE proteins along with other effector molecules. PE/PPE proteins are involved in the activation of immune cells. These proteins, according to the immune system, pose the greatest hazard to the cellular system. Other non-PE/PPE effectors, on the other hand, infiltrate the system and take control of the machinery, inflicting severe damage and pathogenicity.
Comprehensive table showing role of different PE proteins in immune modulation of host.
Sr. No. | PE Proteins | Role in Immune Modulation | Reference |
---|---|---|---|
1. | PE17 |
|
[ |
|
|||
2. | PE6 |
|
[ |
3. | PE31 |
|
[ |
4. | PE13 |
|
[ |
5. | PE27 |
|
[ |
6. | PE11 |
|
[ |
7. | PE5 |
|
[ |
8. | PE15 |
|
[ |
Comprehensive table showing role of different PPE proteins in host immune modulation.
Sr. No. | PPE Proteins | Role in Immune Modulation | Reference |
---|---|---|---|
1. | PPE18 |
|
[ |
2. | PPE65 |
|
[ |
3. | PPE57 |
|
[ |
4. | PPE26 |
|
[ |
5. | PPE60 |
|
[ |
6. | PPE11 |
|
[ |
7. | PPE27 |
|
[ |
8. | PPE44 |
|
[ |
9. | PPE38 |
|
[ |
10. | PPE10 |
|
[ |
11. | PPE32 |
|
[ |
12. | PPE57 |
|
[ |
Comprehensive table showing role of different PE-PGRS proteins in host immune modulation.
Sr. No. | PE_PGRS Proteins | Role in Immune Modulation | Reference |
---|---|---|---|
1. | PE_PGRS41 |
|
[ |
2. | PE_PGRS18 |
|
[ |
3. | PE_PGRS5 |
|
[ |
4. | PE_PGRS11 |
|
[ |
5. | PE_PGRS17 |
|
[ |
6. | PE_PGRS33 |
|
[ |
7. | PE_PGRS62 |
|
[ |
Comprehensive table showing role of different PE/PPE paired proteins in host immune modulation.
Sr. No. | PE/PPE Proteins | Role in Immune Modulation | Reference |
---|---|---|---|
1. | PE32/PPE65 |
|
[ |
2. | PE9/PE10 |
|
[ |
3. | PE25/PPE41 |
|
[ |
4. | PE35/PPE68 |
|
[ |
References
1. Chakaya, J.; Khan, M.; Ntoumi, F.; Aklillu, E.; Fatima, R.; Mwaba, P.; Kapata, N.; Mfinanga, S.; Hasnain, S.E.; Katoto, P.D.M.C. et al. Global Tuberculosis Report 2020; Reflections on the Global TB burden, treatment and prevention efforts. Int. J. Infect. Dis.; 2021; 11, S1201–9712. [DOI: https://dx.doi.org/10.1016/j.ijid.2021.02.107] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33716195]
2. Singh, J.; Ehtesham, N.Z.; Hasnain, S.E. Two parallel pandemics: The challenges faced by countries with COVID-19 and TB. Int. J. Tuberc. Lung Dis.; 2020; 24, pp. 1319-1320. [DOI: https://dx.doi.org/10.5588/ijtld.20.0592]
3. WHO. Global Tuberculosis Report 2019 Geneva. Global Tuberculosis Report 2019; World Health Organization: Geneva, Switzerland, 2020.
4. Ehrt, S.; Schnappinger, D. Mycobacterial survival strategies in the phagosome: Defence against host stresses. Cell. Microbiol.; 2009; 11, pp. 1170-1178. [DOI: https://dx.doi.org/10.1111/j.1462-5822.2009.01335.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19438516]
5. Meena, L.S. Interrelation of Ca2+ and PE_PGRS proteins during Mycobacterium tuberculosispathogenesis. J. Biosci.; 2019; 44, 24. [DOI: https://dx.doi.org/10.1007/s12038-018-9828-4] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30837375]
6. Nair, S. Immunomodulatory Role of Mycobacterial PE/PPE Family of Proteins. Proc. Ind. Natl. Sci. Acad.; 2014; 80, 1055. [DOI: https://dx.doi.org/10.16943/ptinsa/2014/v80i5/47973]
7. Pandey, S.; Tripathi, D.; Khubaib, M.; Kumar, A.; Sheikh, J.A.; Sumanlatha, G.; Ehtesham, N.Z.; Hasnain, S.E. Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Are Immunogenic, Alter Cytokine Profile and Aid in Intracellular Survival. Front. Cell. Infect. Microbiol.; 2017; 7, 38. [DOI: https://dx.doi.org/10.3389/fcimb.2017.00038]
8. Gomes, M.S.; Paul, S.; Moreira, A.L.; Appelberg, R.; Rabinovitch, M.; Kaplan, G. Survival of Mycobacterium avium and Mycobacterium tuberculosis in Acidified Vacuoles of Murine Macrophages. Infect. Immun.; 1999; 67, pp. 3199-3206. [DOI: https://dx.doi.org/10.1128/IAI.67.7.3199-3206.1999]
9. Meena, L.S. Rajni Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J.; 2010; 277, pp. 2416-2427. [DOI: https://dx.doi.org/10.1111/j.1742-4658.2010.07666.x]
10. Baena, A.; Porcelli, S.A. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens; 2009; 74, pp. 189-204. [DOI: https://dx.doi.org/10.1111/j.1399-0039.2009.01301.x]
11. Goldberg, M.F.; Saini, N.K.; Porcelli, S.A. Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis. Microbiol. Spectr.; 2014; 2, [DOI: https://dx.doi.org/10.1128/microbiolspec.MGM2-0005-2013]
12. Paulus, J.K.; Van Der Hoorn, R.A.L. Tricked or trapped—Two decoy mechanisms in host–pathogen interactions. PLoS Pathog.; 2018; 14, e1006761. [DOI: https://dx.doi.org/10.1371/journal.ppat.1006761] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29447267]
13. Ahmed, N.; Dobrindt, U.; Hacker, J.; Hasnain, S. Genomic fluidity and pathogenic bacteria: Applications in diagnostics, epidemiology and intervention. Nat. Rev. Genet.; 2008; 6, pp. 387-394. [DOI: https://dx.doi.org/10.1038/nrmicro1889]
14. Sampson, S.L. Mycobacterial PE/PPE Proteins at the Host-Pathogen Interface. J. Immunol. Res.; 2011; 2011, 497203. [DOI: https://dx.doi.org/10.1155/2011/497203] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21318182]
15. Van Pittius, N.C.G.; Sampson, S.L.; Lee, H.; Kim, Y.; Van Helden, P.D.; Warren, R.M. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol. Biol.; 2006; 6, 95. [DOI: https://dx.doi.org/10.1186/1471-2148-6-95] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17105670]
16. Ahmad, J.; Khubaib, M.; Sheikh, J.A.; Pancsa, R.; Kumar, S.; Srinivasan, A.; Babu, M.M.; Hasnain, S.E.; Ehtesham, N.Z. Disorder-to-order transition in PE–PPE proteins of Mycobacterium tuberculosis augments the pro-pathogen immune response. FEBS Open Bio; 2019; 10, pp. 70-85. [DOI: https://dx.doi.org/10.1002/2211-5463.12749] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31643141]
17. Akhter, Y.; Ehebauer, M.T.; Mukhopadhyay, S.; Hasnain, S. The PE/PPE multigene family codes for virulence factors and is a possible source of mycobacterial antigenic variation: Perhaps more?. Biochimie; 2012; 94, pp. 110-116. [DOI: https://dx.doi.org/10.1016/j.biochi.2011.09.026] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22005451]
18. Delogu, G.; Pusceddu, C.; Bua, A.; Fadda, G.; Brennan, M.J.; Zanetti, S. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure. Mol. Microbiol.; 2004; 52, pp. 725-733. [DOI: https://dx.doi.org/10.1111/j.1365-2958.2004.04007.x]
19. Cadieux, N.; Parra, M.; Cohen, H.; Maric, D.; Morris, S.L.; Brennan, M.J. Induction of cell death after localization to the host cell mitochondria by the Mycobacterium tuberculosis PE_PGRS33 protein. Microbiology; 2011; 157, pp. 793-804. [DOI: https://dx.doi.org/10.1099/mic.0.041996-0]
20. Bottai, D.; Di Luca, M.; Majlessi, L.; Frigui, W.; Simeone, R.; Sayes, F.; Bitter, W.; Brennan, M.J.; Leclerc, C.; Batoni, G. et al. Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. Mol. Microbiol.; 2012; 83, pp. 1195-1209. [DOI: https://dx.doi.org/10.1111/j.1365-2958.2012.08001.x]
21. Majlessi, L.; Prados-Rosales, R.; Casadevall, A.; Brosch, R. Release of mycobacterial antigens. Immunol. Rev.; 2015; 264, pp. 25-45. [DOI: https://dx.doi.org/10.1111/imr.12251] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25703550]
22. Mohareer, K.; Tundup, S.; Hasnain, S. Transcriptional Regulation of Mycobacterium tuberculosis PE/PPE Genes: A Molecular Switch to Virulence. J. Mol. Microbiol. Biotechnol.; 2011; 21, pp. 97-109. [DOI: https://dx.doi.org/10.1159/000329489] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22286037]
23. Balaji, K.N.; Goyal, G.; Narayana, Y.; Srinivas, M.; Chaturvedi, R.; Mohammad, S. Apoptosis triggered by Rv1818c, a PE family gene from Mycobacterium tuberculosis is regulated by mitochondrial intermediates in T cells. Microbes Infect.; 2007; 9, pp. 271-281. [DOI: https://dx.doi.org/10.1016/j.micinf.2006.11.013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17223373]
24. Kaufmann, S.H.E. How can immunology contribute to the control of tuberculosis?. Nat. Rev. Immunol.; 2001; 1, pp. 20-30. [DOI: https://dx.doi.org/10.1038/35095558] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11905811]
25. Thi, E.P.; Lambertz, U.; Reiner, N.E. Sleeping with the Enemy: How Intracellular Pathogens Cope with a Macrophage Lifestyle. PLoS Pathog.; 2012; 8, e1002551. [DOI: https://dx.doi.org/10.1371/journal.ppat.1002551]
26. Basu, S.; Pathak, S.K.; Banerjee, A.; Pathak, S.; Bhattacharyya, A.; Yang, Z.; Talarico, S.; Kundu, M.; Basu, J. Execution of Macrophage Apoptosis by PE_PGRS33 of Mycobacterium tuberculosis Is Mediated by Toll-like Receptor 2-dependent Release of Tumor Necrosis Factor-α. J. Biol. Chem.; 2007; 282, pp. 1039-1050. [DOI: https://dx.doi.org/10.1074/jbc.M604379200] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17095513]
27. Beaulieu, A.M.; Rath, P.; Imhof, M.; Siddall, M.E.; Roberts, J.; Schnappinger, D.; Nathan, C.F. Genome-Wide Screen for Mycobacterium tuberculosis Genes That Regulate Host Immunity. PLoS ONE; 2010; 5, e15120. [DOI: https://dx.doi.org/10.1371/journal.pone.0015120] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21170273]
28. Bansal, K.; Sinha, A.Y.; Ghorpade, D.S.; Togarsimalemath, S.K.; Patil, S.A.; Kaveri, S.V.; Balaji, K.N.; Bayry, J. Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-κB signaling and drives Th2 immune responses. J. Biol. Chem.; 2010; 285, pp. 36511-36522. [DOI: https://dx.doi.org/10.1074/jbc.M110.158055] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20837474]
29. Daim, S.; Kawamura, I.; Tsuchiya, K.; Hara, H.; Kurenuma, T.; Shen, Y.; Dewamitta, S.R.; Sakai, S.; Nomura, T.; Qu, H. et al. Expression of the Mycobacterium tuberculosis PPE37 protein in Mycobacterium smegmatis induces low tumour necrosis factor alpha and interleukin 6 production in murine macrophages. J. Med. Microbiol.; 2011; 60, pp. 582-591. [DOI: https://dx.doi.org/10.1099/jmm.0.026047-0]
30. Tiwari, B.M.; Kannan, N.; Vemu, L.; Raghunand, T.R. The Mycobacterium tuberculosis PE Proteins Rv0285 and Rv1386 Modulate Innate Immunity and Mediate Bacillary Survival in Macrophages. PLoS ONE; 2012; 7, e51686. [DOI: https://dx.doi.org/10.1371/journal.pone.0051686]
31. Bhat, K.H.; Das, A.; Srikantam, A.; Mukhopadhyay, S. PPE 2 protein of Mycobacterium tuberculosis may inhibit nitric oxide in activated macrophages. Ann. N. Y. Acad. Sci.; 2013; 1283, pp. 97-101. [DOI: https://dx.doi.org/10.1111/nyas.12070]
32. Singh, V.; Jamwal, S.; Jain, R.; Verma, P.; Gokhale, R.; Rao, K.V. Mycobacterium tuberculosis-Driven Targeted Recalibration of Macrophage Lipid Homeostasis Promotes the Foamy Phenotype. Cell Host Microbe; 2012; 12, pp. 669-681. [DOI: https://dx.doi.org/10.1016/j.chom.2012.09.012] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23159056]
33. Choudhary, R.K.; Mukhopadhyay, S.; Chakhaiyar, P.; Sharma, N.; Murthy, K.J.R.; Katoch, V.M.; Hasnain, S.E. PPE Antigen Rv2430c of Mycobacterium tuberculosis Induces a Strong B-Cell Response. Infect. Immun.; 2003; 71, pp. 6338-6343. [DOI: https://dx.doi.org/10.1128/IAI.71.11.6338-6343.2003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14573653]
34. Tundup, S.; Pathak, N.; Ramanadham, M.; Mukhopadhyay, S.; Murthy, K.J.R.; Ehtesham, N.Z.; Hasnain, S. The Co-Operonic PE25/PPE41 Protein Complex of Mycobacterium tuberculosis Elicits Increased Humoral and Cell Mediated Immune Response. PLoS ONE; 2008; 3, e3586. [DOI: https://dx.doi.org/10.1371/journal.pone.0003586] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18974870]
35. Khubaib, M.; Sheikh, J.A.; Pandey, S.; Srikanth, B.; Bhuwan, M.; Khan, N.; Hasnain, S.E.; Ehtesham, N.Z. Mycobacterium tuberculosis Co-operonic PE32/PPE65 Proteins Alter Host Immune Responses by Hampering Th1 Response. Front. Microbiol.; 2016; 7, 719. [DOI: https://dx.doi.org/10.3389/fmicb.2016.00719] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27242739]
36. Ehtram, A.; Shariq, M.; Ali, S.; Ehtesham, N.Z.; Hasnain, S.E. ESX5 associated PE proteins of Mycobacterium tuberculosis drives Th1 type polarization: An immunomodulatory paradigm. Am. Assoc. Immnol.; 2020; 12, 2680. [DOI: https://dx.doi.org/10.3389/fimmu.2021.696491]
37. Li, H.; Li, Q.; Yu, Z.; Zhou, M.; Xie, J. Mycobacterium tuberculosis PE13 (Rv1195) manipulates the host cell fate via p38-ERK-NF-κB axis and apoptosis. Apoptosis; 2016; 21, pp. 795-808. [DOI: https://dx.doi.org/10.1007/s10495-016-1249-y]
38. Deng, W.; Yang, W.; Zeng, J.; Abdalla, A.E.; Xie, J. Mycobacterium tuberculosis PPE32 promotes cytokines production and host cell apoptosis through caspase cascade accompanying with enhanced ER stress response. Oncotarget; 2016; 7, pp. 67347-67359. [DOI: https://dx.doi.org/10.18632/oncotarget.12030] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27634911]
39. McNamara, M.; Tzeng, S.-C.; Maier, C.; Zhang, L.; Bermudez, L.E. Surface proteome of “Mycobacterium avium subsp. hominissuis” during the early stages of macrophage infection. Infect. Immun.; 2012; 80, pp. 1868-1880. [DOI: https://dx.doi.org/10.1128/IAI.06151-11] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22392927]
40. Singh, P.; Rao, R.N.; Reddy, J.R.C.; Prasad, R.B.N.; Kotturu, S.K.; Ghosh, S.; Mukhopadhyay, S. PE11, a PE/PPE family protein of Mycobacterium tuberculosis is involved in cell wall remodeling and virulence. Sci. Rep.; 2016; 6, 21624. [DOI: https://dx.doi.org/10.1038/srep21624]
41. Iantomasi, R.; Sali, M.; Cascioferro, A.; Palucci, I.; Zumbo, A.; Soldini, S.; Rocca, S.; Greco, E.; Maulucci, G.; De Spirito, M. et al. PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis. Cell. Microbiol.; 2011; 14, pp. 356-367. [DOI: https://dx.doi.org/10.1111/j.1462-5822.2011.01721.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22050772]
42. Dong, D.; Wang, D.; Li, M.; Wang, H.; Yu, J.; Wang, C.; Liu, J.; Gao, Q. PPE38 Modulates the Innate Immune Response and Is Required for Mycobacterium marinum Virulence. Infect. Immun.; 2011; 80, pp. 43-54. [DOI: https://dx.doi.org/10.1128/IAI.05249-11] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22038915]
43. Aguilo, J.; Alonso, H.; Uranga, S.; Marinova, D.; Arbues, A.; De Martino, A.; Anel, A.; Monzon, M.; Badiola, J.; Pardo, J. ESX-1-induced apoptosis is involved in cell-to-cell spread of M ycobacterium tuberculosis. Cell. Microbiol.; 2013; 15, pp. 1994-2005. [DOI: https://dx.doi.org/10.1111/cmi.12169]
44. Grover, S.; Sharma, T.; Singh, Y.; Kohli, S.; Manjunath, P.; Singh, A.; Semmler, T.; Wieler, L.H.; Tedin, K.; Ehtesham, N.Z. et al. The PGRS Domain of Mycobacterium tuberculosis PE_PGRS Protein Rv0297 Is Involved in Endoplasmic Reticulum Stress-Mediated Apoptosis through Toll-Like Receptor 4. mBio; 2018; 9, e01017-18. [DOI: https://dx.doi.org/10.1128/mBio.01017-18] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29921671]
45. Ahmad, J.; Farhana, A.; Pancsa, R.; Arora, S.K.; Srinivasan, A.; Tyagi, A.K.; Babu, M.M.; Ehtesham, N.Z.; Hasnain, S.E. Contrasting Function of Structured N-Terminal and Unstructured C-Terminal Segments of Mycobacterium tuberculosis PPE37 Protein. mBio; 2018; 9, e01712-17. [DOI: https://dx.doi.org/10.1128/mBio.01712-17] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29362230]
46. Tundup, S.; Mohareer, K.; Hasnain, S.E. Mycobacterium tuberculosisPE25/PPE41 protein complex induces necrosis in macrophages: Role in virulence and disease reactivation?. FEBS Open Bio; 2014; 4, pp. 822-828. [DOI: https://dx.doi.org/10.1016/j.fob.2014.09.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25379378]
47. Dheenadhayalan, V.; Delogu, G.; Brennan, M.J. Expression of the PE_PGRS 33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival. Microbes Infect.; 2006; 8, pp. 262-272. [DOI: https://dx.doi.org/10.1016/j.micinf.2005.06.021] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16203168]
48. Kohli, S.; Singh, Y.; Sharma, K.; Mittal, A.; Ehtesham, N.Z.; Hasnain, S.E. Comparative genomic and proteomic analyses of PE/PPE multigene family of Mycobacterium tuberculosis H37Rv and H37Ra reveal novel and interesting differences with implications in virulence. Nucl. Acids Res.; 2012; 40, pp. 7113-7122. [DOI: https://dx.doi.org/10.1093/nar/gks465] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22618876]
49. Bansal, K.; Elluru, S.R.; Narayana, Y.; Chaturvedi, R.; Patil, S.A.; Kaveri, S.V.; Bayry, J.; Balaji, K.N. PE_PGRS Antigens of Mycobacterium tuberculosisInduce Maturation and Activation of Human Dendritic Cells. J. Immunol.; 2010; 184, pp. 3495-3504. [DOI: https://dx.doi.org/10.4049/jimmunol.0903299]
50. Sharma, T.; Grover, S.; Arora, N.; Manjunath, P.; Ehtesham, N.Z.; Hasnain, S.E. PGRS Domain of Rv0297 of Mycobacterium tuberculosis Is Involved in Modulation of Macrophage Functions to Favor Bacterial Persistence. Front. Cell. Infect. Microbiol.; 2020; 10, 451. [DOI: https://dx.doi.org/10.3389/fcimb.2020.00451] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33042856]
51. Sharma, T.; Singh, J.; Grover, S.; Manjunath, P.; Firdos, F.; Alam, A.; Ehtesham, N.Z.; Hasnain, S.E. PGRS Domain of Rv0297 of Mycobacterium tuberculosis Functions in A Calcium Dependent Manner. Int. J. Mol. Sci.; 2021; 22, 9390. [DOI: https://dx.doi.org/10.3390/ijms22179390]
52. Palucci, I.; Camassa, S.; Cascioferro, A.; Sali, M.; Anoosheh, S.; Zumbo, A.; Minerva, M.; Iantomasi, R.; De Maio, F.; Di Sante, G. et al. PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2. PLoS ONE; 2016; 11, e0150800. [DOI: https://dx.doi.org/10.1371/journal.pone.0150800] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26978522]
53. Delogu, G.; Brennan, M.J. Comparative Immune Response to PE and PE_PGRS Antigens of Mycobacterium tuberculosis. Infect. Immun.; 2001; 69, pp. 5606-5611. [DOI: https://dx.doi.org/10.1128/IAI.69.9.5606-5611.2001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11500435]
54. Cohen, I.; Parada, C.; Acosta-Gão, E.; Espitia, C. The PGRS Domain from PE_PGRS33 of Mycobacterium tuberculosis is Target of Humoral Immune Response in Mice and Humans. Front. Immunol.; 2014; 5, 236. [DOI: https://dx.doi.org/10.3389/fimmu.2014.00236]
55. Singh, P.P.; Parra, M.; Cadieux, N.; Brennan, M.J. A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins. Microbiology; 2008; 154, pp. 3469-3479. [DOI: https://dx.doi.org/10.1099/mic.0.2008/019968-0] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18957600]
56. Deng, W.; Li, W.; Zeng, J.; Zhao, Q.; Li, C.; Zhao, Y.; Xie, J. Mycobacterium tuberculosis PPE family protein Rv1808 manipulates cytokines profile via co-activation of MAPK and NF-κB signaling pathways. Cell. Physiol. Biochem.; 2014; 33, pp. 273-288. [DOI: https://dx.doi.org/10.1159/000356668] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24525621]
57. Medha, L.S.; Sharma, S.; Sharma, M. Proline-Glutamate/Proline-Proline-Glutamate (PE/PPE) proteins of Mycobacterium tuberculosis: The multifaceted immune-modulators. Acta Trop.; 2021; 222, 106035. [DOI: https://dx.doi.org/10.1016/j.actatropica.2021.106035]
58. Sharma, N.; Shariq, M.; Quadir, N.; Singh, J.; Sheikh, J.A.; Hasnain, S.E.; Ehtesham, N.Z. Mycobacterium tuberculosis Protein PE6 (Rv0335c), a Novel TLR4 Agonist, Evokes an Inflammatory Response and Modulates the Cell Death Pathways in Macrophages to Enhance Intracellular Survival. Front. Immunol.; 2021; 12, 696491. [DOI: https://dx.doi.org/10.3389/fimmu.2021.696491] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34322125]
59. Meena, L.S. An overview to understand the role of PE_PGRS family proteins inMycobacterium tuberculosisH37Rv and their potential as new drug targets. Biotechnol. Appl. Biochem.; 2014; 62, pp. 145-153. [DOI: https://dx.doi.org/10.1002/bab.1266] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24975480]
60. Singh, S.K.; Tripathi, D.K.; Singh, P.K.; Sharma, S.; Srivastava, K.K. Protective and survival efficacies of Rv0160c protein in murine model of Mycobacterium tuberculosis. Appl. Microbiol. Biotechnol.; 2012; 97, pp. 5825-5837. [DOI: https://dx.doi.org/10.1007/s00253-012-4493-2] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23104642]
61. Chatrath, S.; Gupta, V.K.; Dixit, A.; Garg, L.C. The Rv1651c-encoded PE-PGRS30 protein expressed in Mycobacterium smegmatis exhibits polar localization and modulates its growth profile. FEMS Microbiol. Lett.; 2011; 322, pp. 194-199. [DOI: https://dx.doi.org/10.1111/j.1574-6968.2011.02354.x]
62. Chatrath, S.; Gupta, V.K.; Dixit, A.; Garg, L.C. PE_PGRS30 of Mycobacterium tuberculosis mediates suppression of proinflammatory immune response in macrophages through its PGRS and PE domains. Microbes Infect.; 2016; 18, pp. 536-542. [DOI: https://dx.doi.org/10.1016/j.micinf.2016.04.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27129781]
63. Gallant, J.; Heunis, T.; Beltran, C.; Schildermans, K.; Bruijns, S.; Mertens, I.; Bitter, W.; Sampson, S.L. PPE38-Secretion-Dependent Proteins of M. tuberculosis Alter NF-kB Signalling and Inflammatory Responses in Macrophages. Front. Immunol.; 2021; 12, 2440. [DOI: https://dx.doi.org/10.3389/fimmu.2021.702359] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34276695]
64. Nair, S.; Ramaswamy, P.A.; Ghosh, S.; Joshi, D.; Pathak, N.; Siddiqui, I.; Sharma, P.; Hasnain, S.; Mande, S.C.; Mukhopadhyay, S. The PPE18 ofMycobacterium tuberculosisInteracts with TLR2 and Activates IL-10 Induction in Macrophage. J. Immunol.; 2009; 183, pp. 6269-6281. [DOI: https://dx.doi.org/10.4049/jimmunol.0901367] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19880448]
65. Nair, S.; Pandey, A.D.; Mukhopadhyay, S. The PPE18 Protein ofMycobacterium tuberculosisInhibits NF-κB/rel–Mediated Proinflammatory Cytokine Production by Upregulating and Phosphorylating Suppressor of Cytokine Signaling 3 Protein. J. Immunol.; 2011; 186, pp. 5413-5424. [DOI: https://dx.doi.org/10.4049/jimmunol.1000773] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21451109]
66. Chakhaiyar, P.; Nagalakshmi, Y.; Aruna, B.; Murthy, K.J.R.; Katoch, V.M.; Hasnain, S.E. Regions of High Antigenicity within the Hypothetical PPE Major Polymorphic Tandem Repeat Open-Reading Frame, Rv2608, Show a Differential Humoral Response and a Low T Cell Response in Various Categories of Patients with Tuberculosis. J. Infect. Dis.; 2004; 190, pp. 1237-1244. [DOI: https://dx.doi.org/10.1086/423938]
67. Huang, Y.; Zhou, X.; Bai, Y.; Yang, L.; Yin, X.; Wang, Z.; Zhao, D. Phagolysosome maturation of macrophages was reduced by PE_PGRS 62 protein expressing in Mycobacterium smegmatis and induced in IFN-γ priming. Vet. Microbiol.; 2012; 160, pp. 117-125. [DOI: https://dx.doi.org/10.1016/j.vetmic.2012.05.011] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22658664]
68. Thi, E.P.; Hong, C.J.H.; Sanghera, G.; Reiner, N.E. Identification of theMycobacterium tuberculosisprotein PE-PGRS62 as a novel effector that functions to block phagosome maturation and inhibit iNOS expression. Cell. Microbiol.; 2012; 15, pp. 795-808. [DOI: https://dx.doi.org/10.1111/cmi.12073]
69. Koh, K.W.; Soh, S.E.; Seah, G.T. Strong Antibody Responses to Mycobacterium tuberculosis PE-PGRS62 Protein Are Associated with Latent and Active Tuberculosis. Infect. Immun.; 2009; 77, pp. 3337-3343. [DOI: https://dx.doi.org/10.1128/IAI.01175-08] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19487480]
70. Tiwari, B.; Sorry, A.; Raghunand, T.R. An immunomodulatory role for the M ycobacterium tuberculosis region of difference 1 locus proteins PE 35 (R v3872) and PPE 68 (R v3873). FEBS J.; 2014; 281, pp. 1556-1570. [DOI: https://dx.doi.org/10.1111/febs.12723]
71. Tundup, S.; Akhter, Y.; Thiagarajan, D.; Hasnain, S. Clusters of PE and PPE genes ofMycobacterium tuberculosisare organized in operons: Evidence that PE Rv2431c is co-transcribed with PPE Rv2430c and their gene products interact with each other. FEBS Lett.; 2006; 580, pp. 1285-1293. [DOI: https://dx.doi.org/10.1016/j.febslet.2006.01.042]
72. Riley, R.; Pellegrini, M.; Eisenberg, D. Identifying cognate binding pairs among a large set of paralogs: The case of PE/PPE Proteins of Mycobacterium tuberculosis. PLoS Commpuattional Biol.; 2008; 4, e1000174. [DOI: https://dx.doi.org/10.1371/journal.pcbi.1000174]
73. Tiwari, B.; Ramakrishnan, U.M.; Raghunand, T.R. The Mycobacterium tuberculosis protein pair PE9 (Rv1088)-PE10 (Rv1089) forms heterodimers and induces macrophage apoptosis through Toll-like receptor 4. Cell. Microbiol.; 2015; 17, pp. 1653-1669. [DOI: https://dx.doi.org/10.1111/cmi.12462] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26031846]
74. Ehtram, A.; Shariq, M.; Ali, S.; Quadir, N.; Sheikh, J.A.; Ahmad, F.; Sharma, T.; Ehtesham, N.Z.; Hasnain, S.E. Teleological cooption of Mycobacterium tuberculosis PE/PPE proteins as porins: Role in molecular immigration and emigration. Int. J. Med. Microbiol.; 2021; 311, 151495. [DOI: https://dx.doi.org/10.1016/j.ijmm.2021.151495] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33730677]
75. Delogu, G.; Bigi, F.; Hasnain, S.E.; Cataldi, A. Enigmatic Proteins from the Surface: The Erp, PE, and PPE Protein Families; Wiley: Hoboken, NJ, USA, 2014; pp. 133-151. [DOI: https://dx.doi.org/10.1128/9781555815783.ch8]
76. Bowie, A.G.; Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol.; 2008; 8, pp. 911-922. [DOI: https://dx.doi.org/10.1038/nri2436]
77. Finlay, B.B.; McFadden, G. Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens. Cell; 2006; 124, pp. 767-782. [DOI: https://dx.doi.org/10.1016/j.cell.2006.01.034] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16497587]
78. Antoniou, A.N.; Powis, S. Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Immunology; 2008; 124, pp. 1-12. [DOI: https://dx.doi.org/10.1111/j.1365-2567.2008.02804.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18284468]
79. Woolard, M.D.; Frelinger, J.A. Outsmarting the host: Bacteria modulating the immune response. Immunol. Res.; 2008; 41, pp. 188-202. [DOI: https://dx.doi.org/10.1007/s12026-008-8021-5]
80. Yu, X.; Feng, J.; Huang, L.; Gao, H.; Liu, J.; Bai, S.; Wu, B.; Xie, J. Molecular Basis Underlying Host Immunity Subversion by Mycobacterium tuberculosis PE/PPE Family Molecules. DNA Cell Biol.; 2019; 38, pp. 1178-1187. [DOI: https://dx.doi.org/10.1089/dna.2019.4852] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31580738]
81. Koh, K.W.; Lehming, N.; Seah, G.T. Degradation-resistant protein domains limit host cell processing and immune detection of mycobacteria. Mol. Immunol.; 2009; 46, pp. 1312-1318. [DOI: https://dx.doi.org/10.1016/j.molimm.2008.11.008] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19128836]
82. Mohan, A.; Jr., W.J.S.; Radivojac, P.; Dunker, A.K.; Uversky, V.N. Intrinsic disorder in pathogenic and non-pathogenic microbes: Discovering and analyzing the unfoldomes of early-branching eukaryotes. Mol. BioSyst.; 2008; 4, pp. 328-340. [DOI: https://dx.doi.org/10.1039/b719168e]
83. Tompa, P. Intrinsically unstructured proteins. Trends Biochem. Sci.; 2002; 27, pp. 527-533. [DOI: https://dx.doi.org/10.1016/S0968-0004(02)02169-2]
84. Via, A.; Uyar, B.; Brun, C.; Zanzoni, A. How pathogens use linear motifs to perturb host cell networks. Trends Biochem. Sci.; 2015; 40, pp. 36-48. [DOI: https://dx.doi.org/10.1016/j.tibs.2014.11.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25475989]
85. Van Der Lee, R.; Buljan, M.; Lang, B.; Weatheritt, R.J.; Daughdrill, G.W.; Dunker, A.K.; Fuxreiter, M.; Gough, J.; Gsponer, J.; Jones, D.T. et al. Classification of Intrinsically Disordered Regions and Proteins. Chem. Rev.; 2013; 114, pp. 6589-6631. [DOI: https://dx.doi.org/10.1021/cr400525m] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24773235]
86. Davey, N.E.; Travé, G.; Gibson, T.J. How viruses hijack cell regulation. Trends Biochem. Sci.; 2011; 36, pp. 159-169. [DOI: https://dx.doi.org/10.1016/j.tibs.2010.10.002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21146412]
87. Blundell, T.L.; Gupta, M.N.; Hasnain, S.E. Intrinsic disorder in proteins: Relevance to protein assemblies, drug design and host-pathogen interactions. Prog. Biophys. Mol. Biol.; 2020; 156, pp. 34-42. [DOI: https://dx.doi.org/10.1016/j.pbiomolbio.2020.06.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32628954]
88. Ehtesham, N.Z.; Ahmad, J.; Farhan, A.; Khubaib, M.; Kaur, S.; Pancsa, R.; Srinivasan, A.; Kumar, S.; Babu, M.; Hasnain, S.E. Intrinsically Disordered Regions/Proteins Compensate for Genomic Economization In Mycobacterium tuberculosis. FASEB J.; 2018; 32, 526.23. [DOI: https://dx.doi.org/10.1096/fasebj.2018.32.1_supplement.526.23]
89. Janeway, C.A., Jr.; Travers, P.M.W. Pathogens have evolved various means of evading or subverting normal host defenses. Immunobiology: The Immune System in Health and Disease; Chapter 11 5th ed. Garland Science: New York, NY. USA, 2001.
90. Mohan, G.S.; Li, W.; Ye, L.; Compans, R.W.; Yang, C. Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus. PLoS Pathog.; 2012; 8, e1003065. [DOI: https://dx.doi.org/10.1371/journal.ppat.1003065]
91. Yeruva, V.C.; Kulkarni, A.; Khandelwal, R.; Sharma, Y.; Raghunand, T.R. The PE_PGRS Proteins of Mycobacterium tuberculosis Are Ca2+ Binding Mediators of Host–Pathogen Interaction. Biochemistry; 2016; 55, pp. 4675-4687. [DOI: https://dx.doi.org/10.1021/acs.biochem.6b00289]
92. Ramakrishnan, L.; Federspiel, N.A.; Falkow, S. Granuloma-Specific Expression of Mycobacterium Virulence Proteins from the Glycine-Rich PE-PGRS Family. Science; 2000; 288, pp. 1436-1439. [DOI: https://dx.doi.org/10.1126/science.288.5470.1436]
93. Zhong, Z.; Wheeler, M.D.; Li, X.; Froh, M.; Schemmer, P.; Yin, M.; Bunzendaul, H.; Bradford, B.; Lemasters, J.J. L-Glycine: A novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr. Opin. Clin. Nutr. Metab. Care; 2003; 6, pp. 229-240. [DOI: https://dx.doi.org/10.1097/00075197-200303000-00013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12589194]
94. Cole, S.T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S.V.; Eiglmeier, K.; Gas, S.; Barry, C.E. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature; 1998; 396, 190. [DOI: https://dx.doi.org/10.1038/24206]
95. Harding, C.V.; Boom, W.H. Regulation of antigen presentation by Mycobacterium tuberculosis: A role for Toll-like receptors. Nat. Rev. Genet.; 2010; 8, pp. 296-307. [DOI: https://dx.doi.org/10.1038/nrmicro2321] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20234378]
96. Grotzke, J.E.; Siler, A.C.; Lewinsohn, D.A.; Lewinsohn, D.M. Secreted Immunodominant Mycobacterium tuberculosis Antigens Are Processed by the Cytosolic Pathway. J. Immunol.; 2010; 185, pp. 4336-4343. [DOI: https://dx.doi.org/10.4049/jimmunol.1000801] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20802151]
97. Bettencourt, P.; Müller, J.; Nicastri, A.; Cantillon, D.; Madhavan, M.; Charles, P.D.; Fotso, C.B.; Wittenberg, R.; Bull, N.; Pinpathomrat, N. et al. Identification of antigens presented by MHC for vaccines against tuberculosis. Vaccines; 2020; 5, pp. 1-14. [DOI: https://dx.doi.org/10.1038/s41541-019-0148-y]
98. Winslow, G.M.; Cooper, A.; Reiley, W.; Chatterjee, M.; Woodland, D.L. Early T-cell responses in tuberculosis immunity. Immunol. Rev.; 2008; 225, pp. 284-299. [DOI: https://dx.doi.org/10.1111/j.1600-065X.2008.00693.x]
99. Bold, T.D.; Banaei, N.; Wolf, A.J.; Ernst, J.D. Suboptimal Activation of Antigen-Specific CD4+ Effector Cells Enables Persistence of M. tuberculosis In Vivo. PLoS Pathog.; 2011; 7, e1002063. [DOI: https://dx.doi.org/10.1371/journal.ppat.1002063] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21637811]
100. Arlehamn, C.S.L.; Gerasimova, A.; Mele, F.; Henderson, R.; Swann, J.; Greenbaum, J.A.; Kim, Y.; Sidney, J.; James, E.A.; Taplitz, R. et al. Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset. PLoS Pathog.; 2013; 9, e1003130. [DOI: https://dx.doi.org/10.1371/journal.ppat.1003130]
101. Dheenadhayalan, V.; Delogu, G.; Sanguinetti, M.; Fadda, G.; Brennan, M.J. Variable Expression Patterns of Mycobacterium tuberculosis PE_PGRS Genes: Evidence that PE_PGRS16 and PE_PGRS26 Are Inversely Regulated In Vivo. J. Bacteriol.; 2006; 188, pp. 3721-3725. [DOI: https://dx.doi.org/10.1128/JB.188.10.3721-3725.2006]
102. Dillon, D.C.; Alderson, M.R.; Day, C.H.; Lewinsohn, D.; Coler, R.; Bement, T.; Campos-Neto, A.; Skeiky, Y.A.W.; Orme, I.M.; Roberts, A. et al. Molecular Characterization and Human T-Cell Responses to a Member of a Novel Mycobacterium tuberculosis mtb39 Gene Family. Infect. Immun.; 1999; 67, pp. 2941-2950. [DOI: https://dx.doi.org/10.1128/IAI.67.6.2941-2950.1999] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10338503]
103. Bonanni, D.; Rindi, L.; Lari, N.; Garzelli, C. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. J. Med. Microbiol.; 2005; 54, pp. 443-448. [DOI: https://dx.doi.org/10.1099/jmm.0.45960-0] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15824420]
104. Ates, L.S.; Sayes, F.; Frigui, W.; Ummels, R.; Damen, M.P.M.; Bottai, D.; Behr, M.A.; van Heijst, J.W.J.; Bitter, W.; Majlessi, L. et al. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection. PLoS Pathog.; 2018; 14, e1007139. [DOI: https://dx.doi.org/10.1371/journal.ppat.1007139] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29912964]
105. Abo-Kadoum, M.; Assad, M.; Ali, K.; Uae, M.; Nzaou, S.A.; Gong, Z.; Moaaz, A.; Lambert, N.; Eltoukhy, A.; Xie, J. Mycobacterium tuberculosis PE17 (Rv1646) promotes host cell apoptosis via host chromatin remodeling mediated by reduced H3K9me3 occupancy. Microb. Pathog.; 2021; 159, 105147. [DOI: https://dx.doi.org/10.1016/j.micpath.2021.105147] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34400280]
106. Yi, F.; Hu, J.; Zhu, X.; Wang, Y.; Yu, Q.; Deng, J.; Huang, X.; Ma, Y.; Xie, Y. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated with Type I Interferon Signaling. Front. Cell. Infect. Microbiol.; 2021; 11, 762. [DOI: https://dx.doi.org/10.3389/fcimb.2021.716809] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34490145]
107. Ali, K.; Zhen, G.; Nzungize, L.; Stojkoska, A.; Duan, X.; Li, C.; Duan, W.; Xu, J.; Xie, J. Mycobacterium tuberculosis PE31 (Rv3477) Attenuates Host Cell Apoptosis and Promotes Recombinant, M. smegmatis Intracellular Survival via Up-regulating GTPase Guanylate Binding Protein-1. Front. Cell. Infect. Microbiol.; 2020; 10, 40. [DOI: https://dx.doi.org/10.3389/fcimb.2020.00040]
108. Kim, W.S.; Kim, J.-S.; Bin Cha, S.; Kim, S.J.; Kim, H.; Kwon, K.W.; Han, S.J.; Choi, S.Y.; Shin, S.J. Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection. Immunobiology; 2015; 221, pp. 440-453. [DOI: https://dx.doi.org/10.1016/j.imbio.2015.11.006] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26655143]
109. Deng, W.; Zeng, J.; Xiang, X.; Li, P.; Xie, J. PE11 (Rv1169c) selectively alters fatty acid components of Mycobacterium smegmatis and host cell interleukin-6 level accompanied with cell death. Front. Microbiol.; 2015; 6, 613. [DOI: https://dx.doi.org/10.3389/fmicb.2015.00613] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26157429]
110. Dolasia, K.; Nazar, F.; Mukhopadhyay, S. Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice. Eur. J. Immunol.; 2020; 51, pp. 603-619. [DOI: https://dx.doi.org/10.1002/eji.201848071]
111. Qureshi, R.; Rameshwaram, N.R.; Battu, M.B.; Mukhopadhyay, S. PPE65 of M. tuberculosis regulate pro-inflammatory signalling through LRR domains of Toll like receptor-2. Biochem. Biophys. Res. Commun.; 2018; 508, pp. 152-158. [DOI: https://dx.doi.org/10.1016/j.bbrc.2018.11.094]
112. Xu, Y.; Yang, E.; Huang, Q.; Ni, W.; Kong, C.; Liu, G.; Li, G.; Su, H.; Wang, H. PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2. J. Mol. Med.; 2015; 93, pp. 645-662. [DOI: https://dx.doi.org/10.1007/s00109-014-1243-1] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25586105]
113. Su, H.; Kong, C.; Zhu, L.; Huang, Q.; Luo, L.; Wang, H.; Xu, Y. PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response. Oncotarget; 2015; 6, pp. 38517-38537. [DOI: https://dx.doi.org/10.18632/oncotarget.5956]
114. Gong, Z.; Kuang, Z.; Li, H.; Li, C.; Ali, M.K.; Huang, F.; Li, P.; Li, Q.; Huang, X.; Ren, S. Regulation of host cell pyroptosis and cytokines production by Mycobacterium tuberculosis effector PPE60 requires LUBAC mediated NF-κB signaling. Cell. Immunol.; 2019; 335, pp. 41-50. [DOI: https://dx.doi.org/10.1016/j.cellimm.2018.10.009]
115. Su, H.; Zhang, Z.; Liu, Z.; Peng, B.; Kong, C.; Wang, H.; Zhang, Z.; Xu, Y. Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2–dependent maturation of dendritic cells. J. Biol. Chem.; 2018; 293, pp. 10287-10302. [DOI: https://dx.doi.org/10.1074/jbc.RA118.001696] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29739853]
116. Peng, X.; Luo, T.; Zhai, X.; Zhang, C.; Suo, J.; Ma, P.; Wang, C.; Bao, L. PPE11 of Mycobacterium tuberculosis can alter host inflammatory response and trigger cell death. Microb. Pathog.; 2018; 126, pp. 45-55. [DOI: https://dx.doi.org/10.1016/j.micpath.2018.10.031] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30366125]
117. Yang, G.; Luo, T.; Sun, C.; Yuan, J.; Peng, X.; Zhang, C.; Zhai, X.; Bao, L. PPE27 in Mycobacterium smegmatis Enhances Mycobacterial Survival and Manipulates Cytokine Secretion in Mouse Macrophages. J. Interf. Cytokine Res.; 2017; 37, pp. 421-431. [DOI: https://dx.doi.org/10.1089/jir.2016.0126] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28829246]
118. Yu, Z.; Zhang, C.; Zhou, M.; Li, Q.; Li, H.; Duan, W.; Li, X.; Feng, Y.; Xie, J. Mycobacterium tuberculosis PPE44 (Rv2770c) is involved in response to multiple stresses and promotes the macrophage expression of IL-12 p40 and IL-6 via the p38, ERK, and NF-κB signaling axis. Int. Immunopharmacol.; 2017; 50, pp. 319-329. [DOI: https://dx.doi.org/10.1016/j.intimp.2017.06.028]
119. Asaad, M.; Ali, M.K.; Abo-Kadoum, M.; Lambert, N.; Gong, Z.; Wang, H.; Uae, M.; Nazou, S.A.; Kuang, Z.; Xie, J. Mycobacterium tuberculosis PPE10 (Rv0442c) alters host cell apoptosis and cytokine profile via linear ubiquitin chain assembly complex HOIP-NF-κB signaling axis. Int. Immunopharmacol.; 2021; 94, 107363. [DOI: https://dx.doi.org/10.1016/j.intimp.2020.107363]
120. Deng, W.; Long, Q.; Zeng, J.; Li, P.; Yang, W.; Chen, X.; Xie, J. Mycobacterium tuberculosis PE_PGRS41 Enhances the Intracellular Survival of M. smegmatis within Macrophages Via Blocking Innate Immunity and Inhibition of Host Defense. Sci. Rep.; 2017; 7, 46716. [DOI: https://dx.doi.org/10.1038/srep46716]
121. Yang, W.; Deng, W.; Zeng, J.; Ren, S.; Ali, K.; Gu, Y.; Li, Y.; Xie, J. Mycobacterium tuberculosis PE_PGRS18 enhances the intracellular survival of M. smegmatis via altering host macrophage cytokine profiling and attenuating the cell apoptosis. Apoptosis; 2016; 22, pp. 502-509. [DOI: https://dx.doi.org/10.1007/s10495-016-1336-0]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Mycobacterium tuberculosis (M.tb) is a successful pathogen that can reside within the alveolar macrophages of the host and can survive in a latent stage. The pathogen has evolved and developed multiple strategies to resist the host immune responses. M.tb escapes from host macrophage through evasion or subversion of immune effector functions. M.tb genome codes for PE/PPE/PE_PGRS proteins, which are intrinsically disordered, redundant and antigenic in nature. These proteins perform multiple functions that intensify the virulence competence of M.tb majorly by modulating immune responses, thereby affecting immune mediated clearance of the pathogen. The highly repetitive, redundant and antigenic nature of PE/PPE/PE_PGRS proteins provide a critical edge over other M.tb proteins in terms of imparting a higher level of virulence and also as a decoy molecule that masks the effect of effector molecules, thereby modulating immuno-surveillance. An understanding of how these proteins subvert the host immunological machinery may add to the current knowledge about M.tb virulence and pathogenesis. This can help in redirecting our strategies for tackling M.tb infections.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 ICMR-National Institute of Pathology, Ansari Nagar West, New Delhi 110029, India;
2 Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi 110016, India;
3 ICMR-National Institute of Pathology, Ansari Nagar West, New Delhi 110029, India;
4 Jamia Hamdard Institute of Molecular Medicine, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India;
5 Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi (IIT-D), Hauz Khas, New Delhi 110016, India; Department of Life Science, School of Basic Sciences and Research, Sharda University, Knowledge Park III, Greater Noida, Uttar Pradesh 201310, India